发明名称 |
Peripheral administration of proteins including TGF-beta superfamily members for systemic treatment of disorders and disease |
摘要 |
Abstract The present invention is directed to methods and compositions for accomplishing systemic delivery of minimally-soluble bioactive agents such as, but not limited to, proteins of the TGF-p superfamily via a peripheral mode of administration. 5 According to the invention, an exemplary bioactive agent is BMP-7. The invention further provides for minimally-invasive systemic treatment of skeletal disorders such as osteoporosis as well as minimally-invasive systemic treatment of injured or diseased non-mineralized tissues and organs such kidneys. Practice of the invention eliminates adverse side effects at the peripheral site of intravenous administration of the bioactive 10 agent. 4422738_i (GHMatters) P87733.AU 1 |
申请公布号 |
AU2013206499(A1) |
申请公布日期 |
2013.07.11 |
申请号 |
AU20130206499 |
申请日期 |
2013.06.14 |
申请人 |
STRYKER CORPORATION |
发明人 |
GOAD, MARY ELIZABETH PECQUET;HASKELL, MELISSA M.;SCHRIER, DENIS;WOOD, SUSAN A. |
分类号 |
A61K38/18;A61K9/00 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|